195 related articles for article (PubMed ID: 2407654)
1. Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.
Gelber RH; Brennan PJ; Hunter SW; Munn MW; Monson JM; Murray LP; Siu P; Tsang M; Engleman EG; Mohagheghpour N
Infect Immun; 1990 Mar; 58(3):711-8. PubMed ID: 2407654
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.
Gelber RH; Murray L; Siu P; Tsang M
Infect Immun; 1992 May; 60(5):1840-4. PubMed ID: 1563772
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.
Shepard CC; van Landingham RM; Walker LL; Ye SZ
Infect Immun; 1983 Jun; 40(3):1096-103. PubMed ID: 6343239
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.
Gelber RH; Mehra V; Bloom B; Murray LP; Siu P; Tsang M; Brennan PJ
Infect Immun; 1994 Oct; 62(10):4250-5. PubMed ID: 7927681
[TBL] [Abstract][Full Text] [Related]
5. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
6. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
7. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
[TBL] [Abstract][Full Text] [Related]
8. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
Shepard CC; Van Landingham R; Walker LL
Infect Immun; 1976 Oct; 14(4):919-28. PubMed ID: 11189
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of mice against Mycobacterium leprae infection.
Singh NB; Lowe AC; Rees RJ; Colston MJ
Infect Immun; 1989 Feb; 57(2):653-5. PubMed ID: 2643581
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae.
Baumgart KW; McKenzie KR; Radford AJ; Ramshaw I; Britton WJ
Infect Immun; 1996 Jun; 64(6):2274-81. PubMed ID: 8675337
[TBL] [Abstract][Full Text] [Related]
11. Heat stability of Mycobacterium leprae immunogenicity.
Shepard CC; Walker LL; van Landingham R
Infect Immun; 1978 Oct; 22(1):87-93. PubMed ID: 365752
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
13. In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae.
Gill HK; Mustafa AS; Godal T
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):30-5. PubMed ID: 3549938
[TBL] [Abstract][Full Text] [Related]
14. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
15. Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae.
Ngamying M; Sawanpanyalert P; Butraporn R; Nikasri J; Cho SN; Levy L; Brennan PJ
Infect Immun; 2003 Mar; 71(3):1596-8. PubMed ID: 12595485
[TBL] [Abstract][Full Text] [Related]
16. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
17. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
[TBL] [Abstract][Full Text] [Related]
18. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.
Robinson P; Mahadevan PR
J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228
[TBL] [Abstract][Full Text] [Related]
19. Searches among mycobacterial cultures for antileprosy vaccines.
Shepard CC; van Landingham R; Walker LL
Infect Immun; 1980 Sep; 29(3):1034-9. PubMed ID: 7000701
[TBL] [Abstract][Full Text] [Related]
20. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
